Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ARAY Accuray Inc
- Stocks
- Healthcare
- NASDAQ: ARAY
Price (delayed)
$1.59
Market cap
$163.79M
P/E Ratio
159
Dividend/share
N/A
EPS
$0.01
Enterprise value
$297.92M
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. The company invents unique, market-changing solutions that are designed to deliver radiation
Highlights
The EPS has soared by 125% from the previous quarter and by 105% YoY
The net income has surged by 115% since the previous quarter and by 103% year-on-year
The gross margin has declined by 4.5% year-on-year
Accuray's debt has increased by 3.6% YoY
Key stats
What are the main financial stats of ARAY
Market
Valuations
Earnings
Shares outstanding
103.01M
Market cap
$163.79M
Enterprise value
$297.92M
Price to earnings (P/E)
159
Price to book (P/B)
3.3
Price to sales (P/S)
0.35
EV/EBIT
12.8
EV/EBITDA
10.16
EV/Sales
0.64
Revenue
$465.25M
Gross profit
$146.44M
Operating income
$10.42M
Net income
$673,000
EBIT
$23.27M
EBITDA
$29.33M
Free cash flow
$16.86M
Per share
Balance sheet
Liquidity
EPS
$0.01
EPS diluted
$0
Free cash flow per share
$0.16
Book value per share
$0.48
Revenue per share
$4.52
TBVPS
$4.15
Total assets
$484.29M
Total liabilities
$434.71M
Debt
$214.37M
Equity
$49.58M
Working capital
$130.03M
Debt to equity
4.32
Current ratio
1.64
Quick ratio
0.78
Net debt/EBITDA
4.57
Margins
Efficiency
Dividend
EBITDA margin
6.3%
Gross margin
31.5%
Net margin
0.1%
Operating margin
2.2%
Return on assets
0.1%
Return on equity
1.4%
Return on invested capital
6.5%
Return on capital employed
8.3%
Return on sales
5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ARAY stock price
How has the Accuray stock price performed over time
Intraday
1.27%
1 week
0%
1 month
16.48%
1 year
-7.02%
YTD
-19.7%
QTD
-11.17%
Financial performance
How have Accuray's revenue and profit performed over time
Revenue
$465.25M
Gross profit
$146.44M
Operating income
$10.42M
Net income
$673,000
Gross margin
31.5%
Net margin
0.1%
The company's operating income has surged by 117% QoQ
The net income has surged by 115% since the previous quarter and by 103% year-on-year
Accuray's net margin has surged by 110% QoQ and by 102% YoY
The company's operating margin has surged by 100% QoQ
Price vs fundamentals
How does ARAY's price correlate with its fundamentals
Growth
What is Accuray's growth rate over time
Valuation
What is Accuray stock price valuation
P/E
159
P/B
3.3
P/S
0.35
EV/EBIT
12.8
EV/EBITDA
10.16
EV/Sales
0.64
The EPS has soared by 125% from the previous quarter and by 105% YoY
The price to book (P/B) is 35% lower than the 5-year quarterly average of 5.1 and 18% lower than the last 4 quarters average of 4.0
ARAY's equity is up by 21% YoY and by 3.5% QoQ
The price to sales (P/S) is 50% lower than the 5-year quarterly average of 0.7 and 13% lower than the last 4 quarters average of 0.4
Accuray's revenue has increased by 8% YoY and by 2.7% from the previous quarter
Efficiency
How efficient is Accuray business performance
Accuray's ROE has soared by 114% from the previous quarter and by 103% YoY
The company's return on assets has surged by 111% QoQ and by 102% YoY
The ROIC has increased by 27% QoQ
The ROS has grown by 25% from the previous quarter
Dividends
What is ARAY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ARAY.
Financial health
How did Accuray financials performed over time
The company's total assets is 11% higher than its total liabilities
The quick ratio has increased by 15% year-on-year and by 2.6% since the previous quarter
The company's total assets rose by 4.7% YoY
ARAY's equity is up by 21% YoY and by 3.5% QoQ
The company's debt to equity fell by 14% YoY and by 3.1% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.